Skip to main content

Peer Review reports

From: The influence of the combined treatment with Vadimezan (ASA404) and taxol on the growth of U251 glioblastoma xenografts

Original Submission
17 Jan 2012 Submitted Original manuscript
9 Feb 2012 Reviewed Reviewer Report - Dan Duda
27 Mar 2012 Reviewed Reviewer Report - Bernd Joachim Krause
7 May 2012 Author responded Author comments - Dusan Milanovic
Resubmission - Version 2
7 May 2012 Submitted Manuscript version 2
7 May 2012 Author responded Author comments - Dusan Milanovic
Resubmission - Version 3
7 May 2012 Submitted Manuscript version 3
21 May 2012 Reviewed Reviewer Report - Dan Duda
24 May 2012 Reviewed Reviewer Report - Bernd Joachim Krause
Resubmission - Version 4
Submitted Manuscript version 4
Publishing
5 Jun 2012 Editorially accepted
13 Jun 2012 Article published 10.1186/1471-2407-12-242

You can find further information about peer review here.

Back to article page